Abstract
The utilization of iron dextran was investigated in normal subjects, in patients with iron-deficiency anaemia, and in anaemias associated with rheumatoid arthritis, reticulosis, and uraemia. Utilization of iron for haemoglobin formation at 14 days was found to be depressed in patients with rheumatoid arthritis, reticulosis, and uraemia, but when a concomitant iron-deficiency anaemia was present utilization was significantly increased. When iron dextran is used to treat anaemias in such conditions an optimum therapeutic response will be obtained only when bone marrow iron stores are absent. © 1971, British Medical Journal Publishing Group. All rights reserved.
Cite
CITATION STYLE
Davies, A. G., Beamish, M. R., & Jacobs, A. (1971). Utilization of Iron Dextran. British Medical Journal, 1(5741), 146–147. https://doi.org/10.1136/bmj.1.5741.146
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.